课题基金 / 基金详情

The use of beta-blockers and the prevention of cancer-specific mortality

The use of beta-blockers and the prevention of cancer-specific mortality
β-受体阻滞剂的使用和预防癌症特异性死亡率
批准号:
267676
负责人:
Azoulay Laurent
金额:
$9.14万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2012
资助国家:
加拿大
项目状态:
已结题
起止时间:
2012-09-01 至 2014-09-01

项目摘要

项目成果

Azoulay Laurent的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Prostate and breast cancer are the most frequently diagnosed malignant tumors among men and women in developed countries. As a result, the clinical and economic burden of these cancers is likely to increase in the foreseeable future. Recently, several lab
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SGLT-2 Inhibitors and Early Bladder Cancer Events: An International Multi-Centre Study
Cancer pharmacoepidemiology: a population-based assessment of the risks of prescription drugs in vulnerable populations
The use of highly prolactin-elevating antipsychotics and the risk of ovarian and endometrial cancer
The use of glyburide and the risk of cancer in elderly patients with type 2 diabetes
海外基金